C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
10/2011
10/05/2011	CN101351446B Novel fused pyrrole derivatives
10/04/2011	US8030345 Tricyclic pyrazole derivatives as cannabinoid receptor modulators
10/04/2011	CA2507501C 3-aminopyrrolidine derivatives as modulators of chemokine receptors
10/04/2011	CA2438520C Phthalazinone-piperidino-derivatives as pde4 inhibitors
10/04/2011	CA2426031C 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
10/03/2011	WO2011027806A1 Therapeutic agent for anxiety disorders
10/03/2011	CA2772922A1 Therapeutic agent for anxiety disorders
10/03/2011	CA2772920A1 Therapeutic agent for mood disorders
09/2011
09/29/2011	WO2011119870A1 Analogues for the treatment or prevention of flavivirus infections
09/29/2011	WO2011119860A1 Analogues for the treatment or prevention of flavivirus infections
09/29/2011	WO2011119858A1 Analogues for the treatment or prevention of flavivirus infections
09/29/2011	WO2011119853A1 Analogues for the treatment or prevention of flavivirus infections
09/29/2011	WO2011117782A1 A process for the preparation of prasugrel hcl salt
09/29/2011	WO2011117421A1 Tricyclic indole derivatives as pbr ligands
09/29/2011	WO2011116865A1 Materials for organic electroluminescence devices
09/29/2011	US20110237776 Aromatic compounds with sulfur containing ligands
09/29/2011	US20110237617 Thieno[2,3-c] isoquinolines for use as inhibitors of parp
09/29/2011	US20110233535 Organic Semiconductors
09/29/2011	US20110232763 Spirobifluorene-based compound and dye-sensitized solar cell using the same
09/29/2011	CA2794181A1 Analogues for the treatment or prevention of flavivirus infections
09/29/2011	CA2794153A1 Chemical compounds
09/29/2011	CA2794145A1 Analogues for the treatment or prevention of flavivirus infections
09/29/2011	CA2792394A1 Tricyclic indole derivatives as pbr ligands
09/29/2011	CA2788764A1 A process for the preparation of prasugrel hcl salt
09/28/2011	EP2368892A1 Novel compound, process for producing the compound, organic semiconductor material, and organic semiconductor device
09/28/2011	EP2367831A1 A method for the manufacture of highly pure prasugrel
09/28/2011	EP2367826A1 Modulators of amyloid beta.
09/28/2011	EP2367821A1 C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof
09/28/2011	CN102203213A Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/28/2011	CN102199163A 2-hydroxy tetrahydrothiophene derivative, preparation method thereof and application thereof in pharmacy
09/28/2011	CN102199162A Preparation method for olanzapine intermediate compound
09/28/2011	CN102199161A Benzene sulfonic acid clopidogrel with crystal form I, preparation method thereof and application thereof
09/28/2011	CN102199160A Novel method for preparing clopidogrel hydrogen sulfate crystal form I
09/28/2011	CN101824042B Triphenylamine-dithienoindene derivative with photovoltaic property
09/22/2011	WO2011115804A1 Sgc stimulators
09/22/2011	WO2011115435A2 Thiol derivative of biotin, and analysis method of substrate specificity of serine/threonine kinase using same
09/22/2011	WO2011115071A1 Thienopyridine derivative, method for producing same and organic semiconductor device using same
09/22/2011	WO2011092720A3 Pharmaceutical composition of prasugrel and its pharmaceutically acceptable salts and process for their preparation
09/22/2011	US20110230476 Pi3 kinase inhibitors and uses thereof
09/22/2011	US20110230460 Thienotriazolodiazepine derivatives active on apo a
09/22/2011	US20110230419 Iap binding compounds
09/21/2011	EP2365970A1 Pyridazinones and their use as btk inhibitors
09/21/2011	EP1436298B1 Himbacine analogues as thrombin receptor antagonists
09/21/2011	CN102191037A Organic photoelectric material containing condensed ring thiophene, manufacturing method and application thereof
09/21/2011	CN102191036A Organic photoelectric material containing nitrogen thiophene, manufacturing method and application thereof
09/21/2011	CN102190666A Preparation method of thiophene compounds
09/21/2011	CN102190625A Stilbene tumor targeted medicine Combretastatin A4 analogs
09/21/2011	CN102190621A N-heterocyclyl-phenylsubstituierte cyclische ketoenole
09/20/2011	US8022102 Unsaturated tetracyclic tetrahydrofuran derivatives
09/20/2011	US8022076 Thieno[2,3-d]pyrimidine derivatives as potassium channel modulators; antiarrhythmia agents
09/15/2011	WO2011112687A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease
09/15/2011	WO2011110219A1 A process for making prasugrel
09/15/2011	US20110224445 Novel Compound, Method of Producing the Compound, Organic Semiconductor Material and Organic Semiconductor Device
09/15/2011	US20110224432 Heteroaryl compounds and uses thereof
09/15/2011	US20110224402 Methods for preparing benzodithiophenes
09/15/2011	US20110224251 Therapeutic Pyrazolyl Thienopyridines
09/15/2011	US20110224197 Pyrimidines and pyridines useful as inhibitors of protein kinases
09/15/2011	US20110224155 Modulation of chemosensory receptors and ligands associated therewith
09/15/2011	US20110224078 Substituted Pyridines Having a Herbicidal Effect
09/15/2011	US20110220884 Compound for organic thin-film transistor and organic thin-film transistor using same
09/14/2011	EP2242736B1 Process for the preparation of pharmaceutical intermediates
09/14/2011	CN102186858A A process for the preparation of s-clopidogrel
09/14/2011	CN102186857A Thienopyrimidines for pharmaceutical compositions
09/14/2011	CN102180887A Method for synthesizing 2,5-diethyl phthalate-3,4-ethylene dioxythiophene
09/14/2011	CN101522688B Novel dithiolopyrrolones and their therapeutical applications
09/14/2011	CN101360751B Oxygen linked pyrimidine derivatives
09/13/2011	US8017643 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
09/13/2011	US8017619 Compositions useful as inhibitors of protein kinases
09/13/2011	CA2615921C Hepatitis c inhibitor peptide analogs with a quinoline or a thienopyridine moiety
09/13/2011	CA2425268C Pyridinone derivatives for treatment of atherosclerosis
09/09/2011	WO2011108765A1 Polycyclic compound
09/09/2011	WO2011108611A1 Photoelectric conversion element and photoelectrochemical cell
09/09/2011	WO2010106347A3 Biomolecular labelling using multifunctional biotin analogues
09/08/2011	US20110218202 Soluble guanylate cyclase activators
09/08/2011	US20110217311 Cycloalkyl containing thienopyrimidines for pharmaceutical compositions
09/07/2011	EP2363396A1 Thiophene derivatives as antiviral agents for flavivirus infection
09/07/2011	EP2362876A1 Thienotriazolodiazepine derivatives active on apo a
09/07/2011	EP2065388B1 Pyrazolopyrimidine derivative
09/07/2011	EP1845095B1 1-thio-d-glucitol derivatives
09/07/2011	EP1841756B1 3-heterocyclyl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
09/07/2011	CN102174074A Inhabitors of cancer cell, T-cell and keratinocyte proliferation
09/07/2011	CN101863898B Thieno pyridinone derivative containing piperazidine and preparation method and applications thereof
09/07/2011	CN101087793B Novel substituted thiophenepyrimidinone derivatives as inhibitors of 17beta-hydroxysteroid dehydrogenase
09/06/2011	US8013170 Substituted pyrrolo[1,2-d][1,4]-diazonines and treatment of brain damage
09/06/2011	US8012995 Pharmaceutically active sulfonamide derivatives
09/06/2011	US8012965 e.g. 1-(2-chloro-7-methylthieno[3,2-d]pyrimidin-4-yl)-N3-(5,7-ethano-5,7,8-trihydro-6-methyl-1,6-naphthyridin-3-yl)-1H-1,2,4-triazole-3,5-diamine; angiogenesis inhibitor, antiproliferative agent
09/01/2011	WO2011104340A1 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions
09/01/2011	WO2011104338A1 Halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions
09/01/2011	WO2011104337A1 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions
09/01/2011	WO2011104334A1 4 - [cycloalkyloxy (hetero) arylamino] thieno [2, 3 - d] pyrimidines having mnkl/ mnk2 inhibiting activity for pharmaceutical compositions
09/01/2011	US20110213162 Condensation compound between fluorinated cyclopentane ring and aromatic ring, and process for producing the same
09/01/2011	US20110213123 Compositions and methods for modification of biomolecules
09/01/2011	US20110213119 Fused ring compound, method for producing the same, polymer, organic thin film containing the compound and/or polymer, and organic thin film device and organic thin film transistor each comprising the organic thin film
09/01/2011	US20110212983 Platelet adp receptor inhibitors
09/01/2011	US20110212970 Compounds that modulate intracellular calcium
09/01/2011	US20110212938 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
09/01/2011	US20110212103 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions
09/01/2011	US20110212102 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions
09/01/2011	US20110210319 Compound for organic thin film transistor and organic thin film transistor using the same
09/01/2011	CA2791114A1 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions

1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 214